ArticleBritish journal of pharmacology2014

Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.

O Orstavik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.